AVEO Oncology
AVEO
#7144
Rank
NZ$0.87 B
Marketcap
NZ$25.09
Share price
0.00%
Change (1 day)
161.05%
Change (1 year)

Market capitalization of AVEO Oncology (AVEO)

Last known market cap: NZ$0.87 Billion

On March 24, 2023 AVEO Oncology had a market cap of NZ$0.87 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of AVEO Oncology from 2010 to 2023

End of year Market Cap

Year Marketcap Change
2023NZ$0.82 B0.73%
2022NZ$0.81 B246.82%
2021NZ$0.23 B2.45%
2020NZ$0.23 B54.54%
2019NZ$0.14 B-50.59%
2018NZ$0.30 B-35.09%
2017NZ$0.46 B685.96%
2016NZ$59.14 M-44.79%
2015NZ$0.10 B91.03%
2014NZ$56.07 M-51.4%
2013NZ$0.11 B-73.07%
2012NZ$0.42 B-55%
2011NZ$0.95 B41.11%
2010NZ$0.67 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Eli Lilly
LLY
NZ$1.592 T 182,533.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$337.89 B 38,641.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$47.13 B 5,304.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$137.86 B 15,707.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$206.62 B 23,590.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
NZ$0.37 B-57.09%๐Ÿ‡บ๐Ÿ‡ธ USA